documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

84 rows where agency_id = "FDA", document_type = "Notice" and posted_year = 1998 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_month, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 1

  • 1998 · 84 ✖

document_type 1

  • Notice · 84 ✖

agency_id 1

  • FDA · 84 ✖
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1998-E-0073-0005 FDA Patent Extension 4,490,351 VITREON FDA-1998-E-0073 Determination of Regulatory Review Period for Purposes of Patent Extension; Vitreon Notice General Notice 1998-12-21T05:00:00Z 1998 12 1998-12-21T05:00:00Z 1999-07-16T03:59:59Z 2025-03-05T18:10:58Z 98-33457 0 0 0900006480583e30
FDA-1998-N-0026-0001 FDA Mercury Compounds in Drugs and Food FDA-1998-N-0026 FDA Notice NRD-Notice of Requesting Data, Info, & Views 1998-12-15T05:00:00Z 1998 12     2008-05-16T21:28:54Z   0 0 09000064805648ac
FDA-1984-G-0001-0001 FDA GRAS Status of Selenium When Added to Animal Feeds FDA-1984-G-0001 American Feed Industry Association; Withdrawal of Generally Recognized As Safe (GRAS) Petition - Notice of Withdrawl Notice NWL-Notice of Withdrawl 1998-12-09T05:00:00Z 1998 12     2014-07-17T17:24:14Z   0 0 09000064805a7533
FDA-1997-C-0043-0001 FDA Polyester epoxy urethane adhesive use in contact with food FDA-1997-C-0043 Closure Medical Corp.; Withdrawal of Color Additive Petition Notice Withdrawal 1998-12-07T05:00:00Z 1998 12     2024-11-06T13:59:15Z   0 0 09000064805cfc65
FDA-1998-N-0006-0005 FDA Practices and Procedures; Internal Review of Agency Decision FDA-1998-N-0006 HF-7 Notice NFR-Notice of Final Rule 1998-11-19T05:00:00Z 1998 11     2008-05-16T21:28:34Z   0 0 0900006480558a70
FDA-1998-D-0097-0001 FDA Fast Track Drug Development Programs: Designation, Development, and Application Review FDA-1998-D-0097 Guidance for Industry on Fast Track Drug Development Programs: Designation, Development, and Application Review; Availability; Collection of Information Notice NAD-Notice of Availability of Data 1998-11-19T05:00:00Z 1998 11 1998-11-19T05:00:00Z 1999-02-17T04:59:59Z 2008-11-19T00:03:09Z   0 0 0900006480586ae6
FDA-1998-N-0049-0001 FDA Exemptions from Premarket Notification & Reserved Devices FDA-1998-N-0049 Medical Devices; Revocation of Exemptions from Premarket Notification for Certain Cardiovascular and Physical Medicine Devices Notice Withdrawal 1998-11-19T05:00:00Z 1998 11 1998-11-19T05:00:00Z 1999-01-27T04:59:59Z 2026-01-23T22:34:42Z   0 0 090000648056e79c
FDA-1996-N-0018-0001 FDA MedWatch:FDA's Medical Prod Reporting Program Forms; Agency FDA-1996-N-0018 Agency Information Collection Activities; Proposed Collection; MedWatch: The FDA Medical Products Reporting Program; Comment Request A.G Notice General Notice 1998-11-13T05:00:00Z 1998 11 1998-11-13T05:00:00Z 1999-01-12T04:59:59Z 2024-09-12T15:07:50Z   0 0 09000064804fa4f3
FDA-1998-D-0002-0001 FDA Content & format of 510(k) Washers and Washer-Disinfectors FDA-1998-D-0002 FDA Notice NAD-Notice of Availability of Data 1998-11-06T05:00:00Z 1998 11 1998-11-06T05:00:00Z 1999-02-04T04:59:59Z 2008-05-16T21:17:54Z   0 0 0900006480558677
FDA-1998-D-0039-0003 FDA FDAs transistion plan for existing postmarket surveillance FDA-1998-D-0039 FDA Notice NAD-Notice of Availability of Data 1998-11-06T05:00:00Z 1998 11     2008-05-16T21:23:02Z   0 0 090000648056e4fd
FDA-1998-N-0027-0001 FDA Electronic Reporting of Postmarket Adverse Drug Reactions FDA-1998-N-0027 Electronic Reporting of Postmarketing Adverse Drug Reactions; Request for Comments Notice Proposed Guidelines 1998-11-06T05:00:00Z 1998 11 1998-11-05T05:00:00Z 1999-02-04T04:59:59Z 2024-11-18T16:45:45Z 98-29564 0 0 0900006480564ac8
FDA-1976-N-0520-0011 FDA Certain Drugs Containing Fluoxymesterone & Ethinyl Estrad - OPEN FDA-1976-N-0520 Eli Lilly & Co. and Bristol-Myers Squibb Co.; Withdrawal of Approval of Three New Drug Applications for Estrogen-Androgen Combination Drugs Notice NWL-Notice of Withdrawl 1998-11-04T05:00:00Z 1998 11     2018-08-02T16:31:49Z   0 0 090000648053be5b
FDA-1976-N-0520-0010 FDA Certain Drugs Containing Fluoxymesterone & Ethinyl Estrad - OPEN FDA-1976-N-0520 Eli Lilly & Co. and Bristol-Myers Squibb Co.; Withdrawal of Approval of Three New Drug Applications for Estrogen-Androgen Combination Drugs Notice Withdrawal 1998-11-04T05:00:00Z 1998 11     2018-08-02T16:31:12Z 98-29049 0 0 090000648053be5a
FDA-1997-D-0009-0002 FDA Use of IEC 60601 Standards; Medical Electrical; FDA-1997-D-0009 FDA Notice NAD-Notice of Availability of Data 1998-10-21T04:00:00Z 1998 10     2008-05-16T21:59:17Z   0 0 09000064805c9a37
FDA-1998-D-0021-0001 FDA Industry on ANDA's: Impurities in Drug Substances FDA-1998-D-0021 FDA Notice NEC-Notice of Extension 1998-10-20T04:00:00Z 1998 10 1998-10-20T04:00:00Z 1998-11-24T04:59:59Z 2008-05-16T21:18:01Z   0 0 0900006480564036
FDA-1998-N-0068-0005 FDA Regs for In Vivo Radiopharm used for Diagnosis & Monitoring FDA-1998-N-0068 HFM-17 Notice NEC-Notice of Extension 1998-10-20T04:00:00Z 1998 10 1998-10-20T04:00:00Z 1998-11-17T04:59:59Z 2008-05-16T21:31:26Z   0 0 0900006480571d21
FDA-1998-D-0035-0001 FDA Medical imaging drugs and biologics FDA-1998-D-0035 FDA Notice NAD-Notice of Availability of Data 1998-10-20T04:00:00Z 1998 10 1998-10-20T04:00:00Z 1998-12-15T04:59:59Z 2008-05-16T21:18:11Z   0 0 09000064805657a0
FDA-1998-N-0068-0004 FDA Regs for In Vivo Radiopharm used for Diagnosis & Monitoring FDA-1998-N-0068 HFM-17 Notice NEC-Notice of Extension 1998-10-20T04:00:00Z 1998 10 1998-10-20T04:00:00Z 1998-11-17T04:59:59Z 2008-05-16T21:31:25Z   0 0 0900006480571d20
FDA-1998-N-0070-0001 FDA Privacy Act of 1974; Altered System of Records FDA-1998-N-0070 Privacy Act of 1974; Altered System of Records, Including Addition of Routine Use(s) to an Existing System of Records Notice Privacy Act 1998-10-20T04:00:00Z 1998 10 1998-10-19T04:00:00Z 1998-11-19T04:59:59Z 2024-09-30T18:10:52Z 98–27937 0 0 0900006480571de0
FDA-1998-N-0068-0006 FDA Regs for In Vivo Radiopharm used for Diagnosis & Monitoring FDA-1998-N-0068 HFM-17 Notice NEC-Notice of Extension 1998-10-20T04:00:00Z 1998 10 1998-10-20T04:00:00Z 1998-11-17T04:59:59Z 2008-05-16T21:31:25Z   0 0 0900006480571d22
FDA-1998-N-0107-0002 FDA 30-Day Notices & 135-Day PMA Supplement Review FDA-1998-N-0107 Medical Devices; 30-Day Notices and 135-Day PMA Supplement Review Notice Notice of Final Rule 1998-10-09T04:00:00Z 1998 10     2024-08-21T14:50:19Z   0 0 0900006480587ef2
FDA-1998-N-0053-0001 FDA Products that have been withdrawn or removed from the market FDA-1998-N-0053 FDA Notice NPR-Notice of Proposed Rule-Making 1998-10-09T04:00:00Z 1998 10 1998-10-09T04:00:00Z 1998-11-24T04:59:59Z 2008-05-16T21:29:13Z   0 0 090000648056ea01
FDA-1993-C-0016-0002 FDA Safe Use of Canthaxanthin FDA-1993-C-0016 Listing of Color Additives Exempt from Certification; Canthaxanthin; Confirmation of Effective Date; Correction Notice Notice of Confirmation of Effective Date 1998-10-02T04:00:00Z 1998 10     2024-04-25T17:43:21Z 98-25640 0 0 09000064804fa730
FDA-1984-D-0009-0001 FDA New Animal Drugs In Food Producing Animals FDA-1984-D-0009 FDA Notice N-Notice 1998-09-28T04:00:00Z 1998 9     2008-05-30T22:53:25Z   0 0 09000064805a77e7
FDA-1998-N-0006-0004 FDA Practices and Procedures; Internal Review of Agency Decision FDA-1998-N-0006 HF-27 Notice NCR-Notice of Correction 1998-09-24T04:00:00Z 1998 9     2008-05-16T21:28:34Z   0 0 0900006480558a6f
FDA-1998-N-0006-0003 FDA Practices and Procedures; Internal Review of Agency Decision FDA-1998-N-0006 HF-7 Notice NWL-Notice of Withdrawl 1998-09-24T04:00:00Z 1998 9     2008-05-16T21:28:34Z   0 0 0900006480558a6e
FDA-1998-D-0100-0001 FDA Interpretation on-farm feed mfg and mixing operations FDA-1998-D-0100 FDA Notice NAD-Notice of Availability of Data 1998-09-24T04:00:00Z 1998 9 1998-09-24T04:00:00Z 1998-11-24T04:59:59Z 2008-05-16T21:23:21Z   0 0 090000648058708a
FDA-1998-D-0102-0003 FDA Health Claim or Nutrient Content Claim FDA-1998-D-0102 FDA Notice NCR-Notice of Correction 1998-09-14T04:00:00Z 1998 9     2008-05-16T21:23:24Z   0 0 090000648058738c
FDA-1981-N-0043-0006 FDA Pediculicide Drug Products for OTC Human Use FDA-1981-N-0043 Pediculicide Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment; Correction Notice Correction 1998-09-09T04:00:00Z 1998 9     2021-03-15T13:27:27Z 98-23400 0 0 09000064805af2f7
FDA-1998-N-0041-0003 FDA Elimination of establishment license/product license FDA-1998-N-0041 Biological Products Regulated Under Section 351 of the Public Health Services Act; implementation of Biologics License; Elimination of Establishment License and Product License; Correction Notice Correction 1998-09-04T04:00:00Z 1998 9     2026-01-30T03:45:33Z 98-23586 0 0 090000648056e5a6
FDA-1998-D-0052-0002 FDA Exports/Imports under FDA export reform/enhancement Act 1996 FDA-1998-D-0052 FDA Notice NEC-Notice of Extension 1998-08-27T04:00:00Z 1998 8 1998-08-27T04:00:00Z 1998-11-25T04:59:59Z 2008-05-16T21:23:07Z   0 0 090000648056e979
FDA-1998-N-0029-0001 FDA Device Quality System Warning Letter Draft Pilot FDA-1998-N-0029 Medical Device Warning Letter Pilot Termination Notice General Notice 1998-08-27T04:00:00Z 1998 8     2024-11-14T20:53:05Z 03-3436 0 0 0900006480564dae
FDA-1998-N-0071-0002 FDA Effect of Dietary Supplement on Structure/Function of the Body - CLOSED FDA-1998-N-0071 Regulations on Statements made for Dietary Supplements Concerning the Effects of the Products on the Structure or Function of the Body; Extension of Comment Period Notice NEC-Notice of Extension 1998-08-27T04:00:00Z 1998 8 1998-08-27T04:00:00Z 1998-09-29T03:59:59Z 2008-07-23T23:37:30Z   0 0 09000064805730ad
FDA-1998-N-0103-0003 FDA Section 406b Agency Plan for Compliance & Annual Report FDA-1998-N-0103 FDA Notice NM-Notice of Meeting 1998-08-20T04:00:00Z 1998 8     2008-05-16T21:37:58Z   0 0 090000648058750a
FDA-1998-N-0103-0004 FDA Section 406b Agency Plan for Compliance & Annual Report FDA-1998-N-0103 FDA Notice NM-Notice of Meeting 1998-08-20T04:00:00Z 1998 8     2008-05-16T21:37:58Z   0 0 090000648058750c
FDA-1998-N-0041-0002 FDA Elimination of establishment license/product license FDA-1998-N-0041 Biological Products Regulated Under Section 351 of the Public Health Services Act; implementation of Biologics License; Elimination of Establishment License and Product License; Public Workshop Notice Public Meetings 1998-08-19T04:00:00Z 1998 8 1998-08-19T04:00:00Z 1998-10-15T03:59:59Z 2026-01-30T03:45:58Z 98-21406 0 0 090000648056e59a
FDA-1981-N-0043-0005 FDA Pediculicide Drug Products for OTC Human Use FDA-1981-N-0043 Pediculicide Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment Notice Notice of Final Rule 1998-08-14T04:00:00Z 1998 8     2021-03-15T13:13:26Z 98-21794 0 0 09000064805af2f6
FDA-1998-N-0068-0003 FDA Regs for In Vivo Radiopharm used for Diagnosis & Monitoring FDA-1998-N-0068 FDA Notice NEC-Notice of Extension 1998-08-03T04:00:00Z 1998 8 1998-08-03T04:00:00Z 1998-10-16T03:59:59Z 2008-05-16T21:31:26Z   0 0 0900006480571d19
FDA-1998-N-0068-0002 FDA Regs for In Vivo Radiopharm used for Diagnosis & Monitoring FDA-1998-N-0068 FDA Notice NEC-Notice of Extension 1998-08-03T04:00:00Z 1998 8 1998-08-03T04:00:00Z 1998-10-16T03:59:59Z 2008-05-16T21:31:26Z   0 0 0900006480571d18
FDA-1998-N-0041-0001 FDA Elimination of establishment license/product license FDA-1998-N-0041 Biological Products Regulated Under Section 351 of the Public Health Services Act; implementation of Biologics License; Elimination of Establishment License and Product License Notice Proposed Guidelines 1998-08-03T04:00:00Z 1998 8 1998-08-03T04:00:00Z 1998-10-15T03:59:59Z 2026-01-30T03:46:21Z 98-20427 0 0 090000648056e598
FDA-1976-N-0027-0005 FDA OTC Nasal Decongestants FDA-1976-N-0027 Notice of Final Rule re Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the- Counter Human Use; Amendment of Monograph for OTC Nasal Decongestant Drug Products Notice Notice of Final Rule 1998-07-31T04:00:00Z 1998 7     2015-10-29T19:26:46Z   0 0 090000648051b690
FDA-1997-N-0069-0002 FDA Medical Devices; Preemption of State Product Liability Claim FDA-1997-N-0069 FDA Notice NWL-Notice of Withdrawl 1998-07-31T04:00:00Z 1998 7     2008-05-16T22:01:20Z   0 0 09000064805d054a
FDA-1998-N-0103-0002 FDA Section 406b Agency Plan for Compliance & Annual Report FDA-1998-N-0103 FDA Notice N-Notice 1998-07-31T04:00:00Z 1998 7     2008-05-16T21:37:59Z   0 0 0900006480587503
FDA-1998-N-0103-0001 FDA Section 406b Agency Plan for Compliance & Annual Report FDA-1998-N-0103 FDA Notice NM-Notice of Meeting 1998-07-31T04:00:00Z 1998 7 1998-07-31T04:00:00Z 1998-09-12T03:59:59Z 2008-05-16T21:37:58Z   0 0 090000648058749a
FDA-1997-N-0010-0002 FDA Allogeneic Peripheral and Placental/ Umbilical Cord Blood FDA-1997-N-0010 Hematopoietic Stem/Progenitor Cell Products: Discussion of Unrelated AflogeneicPlacental/Umbilical Cord Blood and Peripheral Blood Cell Banking and Transplantation; Notice of Public Workshop Notice NM-Notice of Meeting 1998-07-31T04:00:00Z 1998 7     2008-11-26T03:37:19Z   0 0 09000064805c9a4f
FDA-1998-D-0101-0001 FDA 180-day Generic Drug Exclusivity under Hatch-Waxman Amendmen FDA-1998-D-0101 FDA Notice NAD-Notice of Availability of Data 1998-07-20T04:00:00Z 1998 7 1998-07-20T04:00:00Z 1998-10-14T03:59:59Z 2008-05-16T21:23:23Z   0 0 09000064805871c3
FDA-1994-N-0036-0001 FDA Order for Certain Class III Devices, including S&E info FDA-1994-N-0036 FDA Notice NFR-Notice of Final Rule 1998-07-06T04:00:00Z 1998 7 1998-07-06T04:00:00Z 1998-07-31T03:59:59Z 2008-05-16T23:15:35Z   0 0 09000064804fd6ba
FDA-1998-N-0106-0001 FDA Chromium/Risk in Adults of Hyperglycemia/Glucose Intolerance FDA-1998-N-0106 FDA Notice NIR-Notice of Interim Rule 1998-06-30T04:00:00Z 1998 6 1998-06-30T04:00:00Z 1998-09-09T03:59:59Z 2008-05-16T21:38:08Z   0 0 0900006480587cc3
FDA-1998-N-0006-0001 FDA Practices and Procedures; Internal Review of Agency Decision FDA-1998-N-0006 Administrative Practices and Procedures; Internal Agency Review of Decisions; Companion Document to Direct Final Rule Notice General Notice 1998-06-25T04:00:00Z 1998 6 1998-06-25T04:00:00Z 1998-09-01T03:59:59Z 2025-02-25T18:16:51Z 98-15814 0 0 0900006480558a26
FDA-1998-N-0006-0002 FDA Practices and Procedures; Internal Review of Agency Decision FDA-1998-N-0006 Administrative Practices and Procedures; Internal Review of Agency Decisions Notice Notice of Final Rule 1998-06-25T04:00:00Z 1998 6 1998-06-25T04:00:00Z 1998-09-01T03:59:59Z 2025-02-25T19:05:13Z 98- 0 0 0900006480558a65
FDA-1998-D-0052-0001 FDA Exports/Imports under FDA export reform/enhancement Act 1996 FDA-1998-D-0052 FDA Notice NAD-Notice of Availability of Data 1998-06-23T04:00:00Z 1998 6 1998-06-23T04:00:00Z 1998-08-27T03:59:59Z 2008-05-16T21:23:07Z   0 0 090000648056e961
FDA-1998-D-0102-0001 FDA Health Claim or Nutrient Content Claim FDA-1998-D-0102 FDA Notice NAD-Notice of Availability of Data 1998-06-12T04:00:00Z 1998 6     2008-05-16T21:23:24Z   0 0 0900006480587328
FDA-1998-D-0098-0001 FDA Stability Testing of Drug Substances and Drug Products FDA-1998-D-0098 FDA Notice NAD-Notice of Availability of Data 1998-06-09T04:00:00Z 1998 6 1998-06-09T04:00:00Z 1998-09-10T03:59:59Z 2008-05-16T21:23:17Z   0 0 0900006480586c2e
FDA-1998-D-0095-0001 FDA Instructions for Submitting Electronic Lot Release Protocols FDA-1998-D-0095 FDA Notice NAD-Notice of Availability of Data 1998-06-05T04:00:00Z 1998 6 1998-06-05T04:00:00Z 1998-08-01T03:59:59Z 2008-05-16T21:23:14Z   0 0 0900006480586845
FDA-1997-D-0027-0002 FDA Providing Clinical Evidence of Effec. for Human Drugs & Biol FDA-1997-D-0027 FDA Notice NAD-Notice of Availability of Data 1998-05-20T04:00:00Z 1998 5     2008-05-16T21:59:18Z   0 0 09000064805ca339
FDA-1998-N-0105-0001 FDA EA's & FONSI's FDA-1998-N-0105 FDA Notice N-Notice 1998-05-19T04:00:00Z 1998 5     2008-05-16T21:38:06Z   0 0 0900006480587b38
FDA-1998-N-0107-0001 FDA 30-Day Notices & 135-Day PMA Supplement Review FDA-1998-N-0107 Medical Devices; 30-Day Notices and 135-Day PMA Supplement Review Notice Notice of Final Rule 1998-05-05T04:00:00Z 1998 5 1998-05-05T04:00:00Z 1998-07-14T03:59:59Z 2026-02-07T03:28:03Z 98-11086 0 0 0900006480587e9f
FDA-1975-N-0013-0001 FDA First Aid; Topical Antimicrobial Drug Products for Over-the-Counter (OTC) Human Use (OPEN) FDA-1975-N-0013 Status of Certain Additional Over-the-Counter Drug Category II and III Active Ingredients Notice Notice of Final Rule 1998-04-22T04:00:00Z 1998 4     2017-11-16T02:02:43Z 98–10578 0 0 09000064805c1d3c
FDA-1987-F-0031-0001 FDA Safe Use of Sucralose as a Non-Nutritive Sweetener in Food FDA-1987-F-0031 McNeil Specialty Products Co. Notice NFR-Notice of Final Rule 1998-04-10T04:00:00Z 1998 4 1998-04-10T04:00:00Z 1998-05-05T03:59:59Z 2008-05-30T22:53:26Z   0 0 090000648046c473
FDA-1993-C-0016-0001 FDA Safe Use of Canthaxanthin FDA-1993-C-0016 Listing of Color Additives Exempt from Certification; Canthaxanthin Notice Notice of Final Rule 1998-04-08T04:00:00Z 1998 4 1998-04-08T04:00:00Z 1998-04-28T03:59:59Z 2024-04-25T17:40:41Z 98-8127 0 0 09000064804fa6ef
FDA-1996-P-0309-0010 FDA Amend 101.12(b) Table 2 on Hard Candies FDA-1996-P-0309 Food Labeling; Serving Sizes; Reference Amounts for Candies; Extension of Comment Period Notice Extension of Comment Period 1998-03-26T05:00:00Z 1998 3 2014-02-20T05:00:00Z 1998-05-27T03:59:59Z 2014-02-21T02:01:24Z   0 0 0900006480504c84
FDA-1993-N-0043-0007 FDA Adverse Experience Reporting Requirements Drug/Biologicals FDA-1993-N-0043 Expedited Safety Reporting Requirements for Human Drug and Biological Products; Correction Notice Correction 1998-03-26T05:00:00Z 1998 3     2024-04-29T15:00:31Z   0 0 09000064804fc45a
FDA-1996-P-0246-0010 FDA Establishes RACCs for Various Types of Food Products Candies FDA-1996-P-0246 Food Labeling; Serving Sizes; Reference Amounts for Candies; Extension Comment Period Notice Notice of Extension 1998-03-25T05:00:00Z 1998 3 2014-02-20T05:00:00Z 1998-05-27T03:59:59Z 2014-02-21T02:01:52Z   0 0 090000648050397a
FDA-1998-F-0072-0001 FDA safe use of ionizing radition for reduction of salmonella. CLOSED FDA-1998-F-0072 Edward S. Josephson Notice NFL-Notice of Filing 1998-03-24T05:00:00Z 1998 3     2008-05-16T21:24:40Z   0 0 0900006480583c06
FDA-1996-P-0016-0003 FDA Amend 'Healthy' Definition re: Sodium Levels FDA-1996-P-0016 HFS-165 Notice NEC-Notice of Extension 1998-03-20T05:00:00Z 1998 3 1998-03-20T05:00:00Z 1998-05-20T03:59:59Z 2008-05-16T22:19:36Z   0 0 09000064804fa0e0
FDA-1998-N-0069-0001 FDA Isomers of Psychotropic substances: three drug substances FDA-1998-N-0069 HFY-20 Notice N-Notice 1998-03-20T05:00:00Z 1998 3 1998-03-20T05:00:00Z 1998-04-18T03:59:59Z 2008-05-16T21:31:28Z   0 0 0900006480571d6b
FDA-1998-N-0068-0001 FDA Regs for In Vivo Radiopharm used for Diagnosis & Monitoring FDA-1998-N-0068 FDA Notice NM-Notice of Meeting 1998-03-05T05:00:00Z 1998 3 1998-03-05T05:00:00Z 1998-03-05T04:59:59Z 2008-05-16T21:31:26Z   0 0 0900006480571cef
FDA-1996-D-0010-0002 FDA ICH/testing for carcinogenicity of pharmaceuticals FDA-1996-D-0010 FDA Notice NAD-Notice of Availability of Data 1998-02-27T05:00:00Z 1998 2     2008-05-16T22:15:19Z   0 0 09000064804f9b2b
FDA-1998-D-0039-0001 FDA FDAs transistion plan for existing postmarket surveillance FDA-1998-D-0039 FDA Notice NAD-Notice of Availability of Data 1998-02-27T05:00:00Z 1998 2 1998-02-27T05:00:00Z 1998-05-27T03:59:59Z 2008-05-16T21:23:02Z   0 0 090000648056e4ed
FDA-1988-P-0024-0002 FDA Section 513(E) reclassification of lipectomy systems-CLOSED FDA-1988-P-0024 FDA Notice NFR-Notice of Final Rule 1998-02-23T05:00:00Z 1998 2     2008-05-30T22:52:53Z   0 0 0900006480476376
FDA-1984-N-0021-0001 FDA Orphan Product Designations FDA-1984-N-0021 FDA Notice NAD-Notice of Availability of Data 1998-02-06T05:00:00Z 1998 2     2008-05-30T22:53:05Z   0 0 09000064805a803a
FDA-1995-M-0032-0001 FDA Premarket approval of VasoSeal Vascular Hemostasis Device FDA-1995-M-0032 Datascope Corp., Premarket Approval of the VasoSeal Vascular Hemostasis Device Notice Notice of Approval 1998-01-29T05:00:00Z 1998 1 1998-01-29T05:00:00Z 1996-01-16T04:59:59Z 2024-07-01T18:24:02Z   0 0 090000648055ac8b
FDA-1990-N-0002-0011 FDA Revise Medical Device CGMP Regulation FDA-1990-N-0002 FDA Notice NM-Notice of Meeting 1998-01-28T05:00:00Z 1998 1     2008-05-16T23:46:14Z   0 0 0900006480525847
FDA-1997-N-0010-0001 FDA Allogeneic Peripheral and Placental/ Umbilical Cord Blood FDA-1997-N-0010 Request for Proposed Standards for Unrelated Allogeneic Peripheral and Placental/Umbilical Cord Blood Hematopoietic Stem/Progenitor Cell Products; Request for Comments Notice N-Notice 1998-01-27T05:00:00Z 1998 1     2008-11-26T03:32:37Z   0 0 09000064805c9a4b
FDA-1997-P-0065-0001 FDA Regulatory Status of Cholestin Red Yeast Rice FDA-1997-P-0065 Administrative Proceeding; Re: Pharmanex, Inc. Notice N-Notice 1998-01-16T05:00:00Z 1998 1 1998-01-16T05:00:00Z 1998-01-31T04:59:59Z 2009-01-08T01:42:41Z   0 0 09000064805d035f
FDA-1997-D-0009-0001 FDA Use of IEC 60601 Standards; Medical Electrical; FDA-1997-D-0009 FDA Notice NAD-Notice of Availability of Data 1998-01-16T05:00:00Z 1998 1 1998-01-16T05:00:00Z 1998-04-14T03:59:59Z 2008-05-16T21:59:17Z   0 0 09000064805c9a34
FDA-1997-M-0061-0001 FDA Premarket Approval of Vitreon FDA-1997-M-0061 Tab C: Vitreon Labeling re: Vitrophage, Inc.; Premarket Approval of VITREON Notice Notice of Approval 1998-01-14T05:00:00Z 1998 1 1998-01-14T05:00:00Z 1998-02-03T04:59:59Z 2024-12-02T14:08:29Z   0 0 09000064805d030e
FDA-1997-M-0061-0003 FDA Premarket Approval of Vitreon FDA-1997-M-0061 Tab A: Order re: Vitrophage, Inc.; Premarket Approval of VITREON Notice Notice of Approval 1998-01-14T05:00:00Z 1998 1 1998-01-14T05:00:00Z 1998-02-03T04:59:59Z 2024-12-02T14:11:06Z   0 0 09000064805d0312
FDA-1997-M-0061-0004 FDA Premarket Approval of Vitreon FDA-1997-M-0061 Vitrophage, Inc.; Premarket Approval of VITREON Notice Notice of Approval 1998-01-14T05:00:00Z 1998 1 1998-01-14T05:00:00Z 1998-02-03T04:59:59Z 2024-12-02T14:04:55Z 97-34157 0 0 09000064805d0313
FDA-1997-M-0061-0002 FDA Premarket Approval of Vitreon FDA-1997-M-0061 Tab B: Summary of Safety and Effectiveness Data re: Vitrophage, Inc.; Premarket Approval of VITREON Notice Notice of Approval 1998-01-14T05:00:00Z 1998 1 1998-01-14T05:00:00Z 1998-02-03T04:59:59Z 2024-12-02T14:09:39Z   0 0 09000064805d0310
FDA-1997-D-0056-0001 FDA Iron-Containing Supplements/Drugs :Label Warning Statements FDA-1997-D-0056 Iron-Containing Supplements and Drugs: Label Warning Statements and Unit-Dose Packaging Requirements; Small Entity Compliance Guide; Availability Notice Notice of Data Availability 1998-01-06T05:00:00Z 1998 1     2024-01-30T19:40:05Z 97-32552 0 0 09000064805cfd30
FDA-1997-N-0069-0001 FDA Medical Devices; Preemption of State Product Liability Claim FDA-1997-N-0069 FDA Notice NPR-Notice of Proposed Rule-Making 1998-01-06T05:00:00Z 1998 1 1998-01-06T05:00:00Z 1998-02-11T04:59:59Z 2008-05-16T22:01:20Z   0 0 09000064805d04fa
FDA-1990-P-0023-0002 FDA Optimum size & Style of print to be used to label OTC Drugs-CLOSED FDA-1990-P-0023 FDA Notice N-Notice 1998-01-02T05:00:00Z 1998 1 1998-01-02T05:00:00Z 1998-02-14T04:59:59Z 2008-05-16T23:50:52Z   0 0 09000064805293bb
FDA-1996-P-0016-0002 FDA Amend 'Healthy' Definition re: Sodium Levels FDA-1996-P-0016 FDA Notice NAP-Advanced Notice of Proposed Rulemaking 1998-01-02T05:00:00Z 1998 1 1998-01-02T05:00:00Z 1998-03-17T04:59:59Z 2008-05-16T22:19:43Z   0 0 09000064804fa09c

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);